Mosaic Therapeutics has appointed Stephen Shuttleworth as chief scientific officer [...]
Shift Bioscience has published new research presenting an improved framework [...]
Enhanced Genomics has secured an additional funding round, bringing its [...]
Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]